23andMe Holding Co. (NASDAQ: ME)
$4.8200
+0.0100 ( +0.21% ) 211.6K
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
Market Data
Open
$4.8200
Previous close
$4.8100
Volume
211.6K
Market cap
$124.28M
Day range
$4.7450 - $5.0390
52 week range
$4.6000 - $20.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 70 | Jul 16, 2024 |
4 | Insider transactions | 4 | Jul 02, 2024 |
4 | Insider transactions | 4 | Jul 02, 2024 |
4 | Insider transactions | 4 | Jul 02, 2024 |
pre | Proxies and info statements | 71 | Jun 27, 2024 |